Executive Summary
The cancer market has undergone a high degree of innovation led change over the previous five years, which has created strong opportunities for a range of established and emerging biotechnology and pharmaceutical companies; the new report ’The Cancer Market Outlook to 2010’ provides detailed analysis on 9 key indications in the cancer market, identifying growth brands, leading companies and epidemiology and product sales forecasts over the period 2005-2010. The 6-year forecasts detailed in this report will enable you to evaluate changes in the competitive positions of leading companies in the cancer market and ensure your R&D pipeline is aligned with future market opportunity to sustain revenue growth. This report will enable you to benchmark the strategies behind the market-leading products of today and identify which products will be best positioned for growth over the period 2005-2010.
Other selected research from the 'Markets' category:
Indias Growth Prospects in Pharma: Evolution, Not Revolution
The Womens Health Outlook to 2008: Market and pipeline analysis of major female disorders
Other selected research from the 'Oncology' category:
Vascular Targeting Agents: Emerging Competitors
Pipeline Insight: Cancer Overview - Lung, Brain, Head and Neck, Thyroid
Other selected research from the 'Markets' category:
Pharmaceuticals in Belgium
Indian Pharmaceutical Market, 2006-2011